Alkylating agents: all 3,295 studies that test it
Page 31 of 33. Open to participants first (456), then studies with results posted, then the rest; newest registration first within each.
- Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent SarcomaWithdrawnNCT00017160Phase 2
- Chlorambucil in Treating Patients With Advanced Chronic Lymphocytic LeukemiaStatus unknownNCT00017108Phase 3
- Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic SclerosisCompletedNCT00016458Phase 2
- Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast CancerTerminatedNCT00016276Phase 3
- Dacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant MelanomaCompletedNCT00016263Phase 3
- Biological Therapy and Temozolomide in Treating Patients With Metastatic MelanomaStatus unknownNCT00016055Phase 1
- Phase I Pilot Study of Total-Body Irradiation, Anti-Thymocyte Globulin and Cyclophosphamide Followed By Syngeneic or Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple SclerosisCompletedNCT00014755Phase 1
- Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain CancerCompletedNCT00014573Phase 2
- Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic CancerCompletedNCT00014469Phase 2
- Temozolomide Plus PEG-Interferon Alfa-2B in Treating Patients With Advanced Solid TumorsCompletedNCT00014261Phase 1
- Combination Chemotherapy in Treating Patients With Recurrent Glioblastoma MultiformeStatus unknownNCT00014105Phase 1/2
- Chemotherapy Followed by Biological Therapy in Treating Patients With Stage IV Melanoma That Cannot be Treated With SurgeryCompletedNCT00014092Phase 2
- Temozolomide in Treating Patients With Solid Tumors That Have Spread to the BrainCompletedNCT00012116Phase 2
- Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory PemphigusCompletedNCT00010413Phase 2
- Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody SyndromeCompletedNCT00010400Not applicable
- Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic DiseaseCompletedNCT00010387Phase 2
- Melphalan and Filgrastim to Stimulate Peripheral Stem Cells in Patients With Multiple MyelomaCompletedNCT00008268Phase 2
- Melphalan With or Without Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple MyelomaCompletedNCT00008229Phase 3
- Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant GliomaCompletedNCT00008008Phase 2
- Adjuvant Stage 2-3A Breast Cancer With Positive Lymph NodesCompletedNCT00007904Phase 2
- Combination Chemotherapy Plus Rituximab in Treating Patients With Recurrent or Refractory Non-Hodgkin's LymphomaCompletedNCT00007865Phase 2
- Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid TumorsCompletedNCT00007813Phase 1
- Temozolomide in Treating Patients With Metastatic Non-small Cell Lung CancerCompletedNCT00006877Phase 2
- Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's LymphomaCompletedNCT00006760Phase 2
- Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell LymphomaCompletedNCT00006747Phase 2
- Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal TumorCompletedNCT00006734Phase 3
- Monoclonal Antibody Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplant in Non-Hodgkin's LymphomaCompletedNCT00006695Phase 2
- Temozolomide and O6-benzylguanine in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Anaplastic GliomaCompletedNCT00006474Phase 1
- Combination Chemotherapy Followed by Second-Look Surgery and Radiation Therapy in Treating Children With Nonmetastatic Medulloblastoma or Primitive Neuroectodermal TumorCompletedNCT00006461Phase 3
- Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma MultiformeCompletedNCT00006386Phase 2
- Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's LymphomaCompletedNCT00006373Phase 2
- Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid LeukemiaCompletedNCT00006363Phase 3
- Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain TumorCompletedNCT00006358Phase 2
- Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00006353Phase 3
- Carboplatin, Temozolomide, and Filgrastim in Treating Patients With Newly Diagnosed or Recurrent High-Grade GliomaWithdrawnNCT00006263Phase 2
- Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplant in Treating Patients With Leukemia or LymphomaCompletedNCT00006252Phase 2
- Busulfan in Treating Children and Adolescents With Refractory CNS CancerCompletedNCT00006246Phase 1
- Thalidomide and Dacarbazine for Metastatic MelanomaStatus unknownNCT00006200Phase 2
- Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal CancerStatus unknownNCT00006112Phase 2
- Temozolomide in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to CisplatinCompletedNCT00006043Phase 2
- Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic CancerCompletedNCT00006042Phase 1
- Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast CancerTerminatedNCT00006032Phase 2
- Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant GliomaCompletedNCT00006025Phase 1
- Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant GliomaCompletedNCT00006024Phase 1
- Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous TherapyCompletedNCT00005988Phase 1
- Chemotherapy, Filgrastim and Peripheral Stem Cell Transplantation in Patients With Chronic Myelogenous LeukemiaTerminatedNCT00005986Phase 2
- Cyclophosphamide and Filgrastim Followed By SCT in Patients With Chronic or Accelerated Phase Myelogenous LeukemiaTerminatedNCT00005984Phase 2
- Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast CancerCompletedNCT00005970Phase 3
- Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Previously Untreated Aggressive Stage II, Stage III, or Stage IV Non-Hodgkin's LymphomaCompletedNCT00005964Phase 2
- O6-benzylguanine and Carmustine in Treating Patients With Unresectable Locally Recurrent or Metastatic MelanomaCompletedNCT00005961Phase 2
- Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone TherapyStatus unknownNCT00005960Phase 2
- Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS TumorsCompletedNCT00005955Phase 2
- Temozolomide in Treating Patients With Brain MetastasesCompletedNCT00005954Phase 2
- Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid TumorsCompletedNCT00005952Phase 1/2
- Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant GliomaCompletedNCT00005951Phase 1
- Chemotherapy Followed by Peripheral Stem Cell Transplantation And Biological Therapy in Treating Patients With Chronic Myelogenous LeukemiaCompletedNCT00005948Phase 2
- Radiolabeled BC8 Antibody, Busulfan, Cyclophosphamide Followed by Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia in First RemissionCompletedNCT00005940Phase 2
- Phase I/II Study of Total Body Irradiation, Cyclophosphamide, and Fludarabine Followed by Alternate Donor Hematopoietic Cell Transplantation in Patients With Fanconi's AnemiaCompletedNCT00005898Phase 1/2
- Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Myelodysplastic Syndrome and Acute Leukemia Related to Fanconi's AnemiaCompletedNCT00005892Not applicable
- Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Fanconi's AnemiaCompletedNCT00005891Not applicable
- S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid LeukemiaCompletedNCT00005866Phase 3
- Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant GliomaCompletedNCT00005855Phase 1/2
- N99-02: Melphalan and Buthionine SulfoximineCompletedNCT00005835Phase 1
- Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV MelanomaCompletedNCT00005815Phase 1/2
- Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or LymphomaTerminatedNCT00005812Phase 2
- Bone Marrow Transplantation in Treating Patients With Hematologic CancerCompletedNCT00005804Phase 2
- Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Women With Breast CancerCompletedNCT00005798Phase 2
- Bone Marrow Transplant in Treating Patients With Hematologic CancersCompletedNCT00005797Phase 2
- Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple MyelomaCompletedNCT00005792Phase 1
- Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant GliomaCompletedNCT00005637Phase 1
- Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic DisordersCompletedNCT00005622Phase 2
- Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's DiseaseCompletedNCT00005613Phase 2
- S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal TumorsCompletedNCT00005597Phase 2
- Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00005596Phase 3
- Combination Chemotherapy in Treating Children With Acute Lymphoblastic LeukemiaCompletedNCT00005585Phase 3
- Combination Chemotherapy in Treating Women With Stage II or Stage III Breast CancerStatus unknownNCT00005581Phase 3
- Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerCompletedNCT00005092Phase 1
- S9901 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Stage III or Stage IV Hodgkin's DiseaseTerminatedNCT00005090Phase 3
- Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive GliomaCompletedNCT00005081Phase 2
- O6-benzylguanine and Carmustine in Treating Patients With Recurrent, Metastatic, or Locally Advanced Soft Tissue SarcomaCompletedNCT00005066Phase 2
- Temozolomide in Treating Women With Advanced Breast CancerStatus unknownNCT00005054Phase 2
- Temozolomide in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung CancerCompletedNCT00005037Phase 2
- Granisetron to Prevent Nausea and Vomiting After Chemotherapy in Patients With Malignant DiseaseStatus unknownNCT00005024Phase 3
- Ifosfamide, Teniposide, and Paclitaxel in Treating Patients With Relapsed Non-Hodgkin's LymphomaCompletedNCT00004916Phase 1/2
- Radiation Therapy and Cyclophosphamide Plus Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's LymphomaCompletedNCT00004908Phase 2
- Radiation Therapy and Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With High-Grade Lymphoma or Acute Lymphoblastic LeukemiaCompletedNCT00004898Phase 1/2
- Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic SyndromeCompletedNCT00004896Phase 2
- Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer That Cannot Be Removed During SurgeryStatus unknownNCT00004887Phase 3
- Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain NeoplasmsCompletedNCT00004688Phase 2
- Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients With Aplastic AnemiaCompletedNCT00004474Phase 3
- Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and Paroxysmal Nocturnal HemoglobinuriaCompletedNCT00004464Phase 2
- Isolated Limb Infusion of Chemotherapy in Treating Patients With Melanoma or Soft Tissue Sarcoma of the Arm or Leg That Cannot Be Removed By SurgeryCompletedNCT00004250Phase 2
- Comparison of Three Combination Chemotherapy Regimens in Treating Women With Stage I or Stage II Breast CancerCompletedNCT00004237Phase 2
- Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic LeukemiaCompletedNCT00004218Phase 3
- Temozolomide in Treating Patients With Recurrent or Progressive Malignant GliomaStatus unknownNCT00004204Phase 2
- Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00004200Phase 2
- Combination Chemotherapy in Treating Patients With Small Cell Lung CancerCompletedNCT00004186Phase 1/2
- Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Stage III Breast CancerCompletedNCT00004175Phase 2
- Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast CancerCompletedNCT00004174Phase 1
- Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple MyelomaCompletedNCT00004165Phase 3